Petmed Express Inc 8-K Filing

FAQ

Filing Documents

• pets-20251208.htm (8-K) — 43KB
• rsmlettertosec.htm (EX-16.1) — 2KB
• 0001040130-25-000097.txt ( ) — 202KB
• pets-20251208.xsd (EX-101.SCH) — 2KB
• pets-20251208_def.xml (EX-101.DEF) — 16KB
• pets-20251208_lab.xml (EX-101.LAB) — 27KB
• pets-20251208_pre.xml (EX-101.PRE) — 16KB
• pets-20251208_htm.xml (XML) — 4KB

01. Changes in Registrant's Certifying Accountant

Item 4.01. Changes in Registrant's Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm On December 8, 2025, the Audit Committee of the Board of Directors (the "Audit Committee") of PetMed Express, Inc. (the "Company"), following a competitive process to determine the Company's independent registered public accounting firm for the fiscal year ended March 31, 2026, approved the engagement of Baker Tilly US, LLP ("Baker Tilly") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026. On the same date, the Company notified RSM US LLP ("RSM") of its dismissal as the Company's independent registered public accounting firm effective as of the completion of RSM's interim review of the quarterly information on Form 10-Q as of and for the three-month periods ended June 30, 2025, and September 30, 2025. Upon completion of such services by RSM, the Company intends to file an amendment to this Current Report on Form 8-K with the specific date of dismissal and an update to the disclosures required by Item 304(a) of Regulation S-K through such date. RSM's reports on the Company's consolidated financial statements for each of the fiscal years ended March 31, 2025 and March 31, 2024 did not contain any adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. During each of the fiscal years ended March 31, 2025 and March 31, 2024, and the subsequent interim periods through the date of dismissal, there were no "disagreements," as that term is defined in Item 304(a)(1)(iv) of Regulation S-K, between the Company and RSM on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of RSM, would have caused RSM to make reference to the subject matter of the disagreement in its reports on the Company's

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 16.1 Letter from RSM US LLP dated December 9 , 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 4

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 9, 2025 PETMED EXPRESS, INC. By: /s/ Robert Lawsky Name: Robert Lawsky Title: General Counsel 5

View Full Filing

View this 8-K filing on SEC EDGAR